More importantly, the importance of the upregulation of PD-L2 in LXN−/− macrophage in tumor immune escape is highlighted by bone marrow transplantation (Fig. 7), adoptive therapy (Fig. 8) and immune checkpoint suppression therapy by targeting blockade of PD-L2 (Fig. 9). This evidence concerns the gene PDCD1LG2 and neoplasm.